We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Alizyme | LSE:AZM | London | Ordinary Share | GB0000374289 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.08 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
04/8/2009 13:41 | Coming from a proven liar. Please post ONE time that I "recommeded" this stock in the whole 8 years I have been here. | vow | |
04/8/2009 10:02 | dunderheed I just hope Tim does not do a management buyout. Slimely little man. | city chappy | |
01/8/2009 16:18 | merete, as usual with computers, you buy software to run on your PC that generates the web pages, then you upload the pages to your web server. I havn't looked into web page generation software for sometime, so I can't tell you which is the current best value software. To be absolutely correct, you can actually generate web pages without buying any software. Just use the free simple text generation program Notepad, that comes with Windows. However, you would have to know how to write html scripts, which you won't if you needed to ask the question above. So it is the hard way, only for those that are extremely tight. LOL! | mad mike | |
01/8/2009 12:16 | Does anyone here know how to design a website? | merete4 | |
01/8/2009 09:42 | Doc, I love the line: "Anyone interested in discussing the acquisition of these products and the associated intellectual property should contact Ian Carr on 01223 225600" Sent out to shareholders! | vow | |
01/8/2009 09:37 | Interesting. A great shame for holders that Tim couldnt get these parties to sign while AZM was still going... That said, it may be that some specifically search around for assets from co.s in administration. I'm not convinced anyone will pay to develop ceti. >>>>>>> Dated: Friday 31 July 2009 - Since Alizyme plc and Alizyme Therapeutics Limited entered administration on Monday 27 July, the administrators, Ian Carr and Nigel Morrison, partners at Grant Thornton UK LLP, have been approached by a number of parties interested in acquiring certain of the companies' products. Ian Carr said: "We are actively talking to a number of parties regarding their possible purchase of cetilistat, a product designed to address obesity, which has completed Phase II development in the West and is in Phase III development in Japan. "We are also talking to a number of parties with regard to the sale of ATL-104, a product for the prevention of mucositis during cancer therapy, that has demonstrated 'proof of concept' in a Phase IIa clinical study." | the_doctor | |
01/8/2009 09:27 | What a laugh VOW, how would anyone with a face like that allow themselves to be photographed!! | birdie4 | |
01/8/2009 03:53 | Administration of Alizyme plc: Update Alizyme (UNITED KINGDOM) July 31, 2009 Dated: Friday 31 July 2009 - Since Alizyme plc and Alizyme Therapeutics Limited entered administration on Monday 27 July, the administrators, Ian Carr and Nigel Morrison, partners at Grant Thornton UK LLP, have been approached by a number of parties interested in acquiring certain of the companies' products. Ian Carr said: "We are actively talking to a number of parties regarding their possible purchase of cetilistat, a product designed to address obesity, which has completed Phase II development in the West and is in Phase III development in Japan. "We are also talking to a number of parties with regard to the sale of ATL-104, a product for the prevention of mucositis during cancer therapy, that has demonstrated 'proof of concept' in a Phase IIa clinical study." Anyone interested in discussing the acquisition of these products and the associated intellectual property should contact Ian Carr on 01223 225600. For more information contact Cathy Connan on 07976 669089 or email cathy@cathyconnan.co Grant Thornton UK LLP is a leading financial and business adviser with 30 locations nationwide. We are the UK member of Grant Thornton International, one of the world's leading international organisations of independently owned and managed accounting and consulting firms. Although Grant Thornton International is not a worldwide partnership, the firms share a commitment to providing the same high quality service to their clients wherever they do business | yaki | |
01/8/2009 01:56 | This is not a financial issue, and I only wish I had shorted more when I did and closed too early. This is an issue of integrity, something you clearly do not have. | silverbackalpha | |
01/8/2009 00:54 | Mole where does that info come from. Is there any substance to it? | billthebank |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions